A combined clinicopathologic and gene expression model (CP-GEP) identifies primary cutaneous melanoma patients who can safely forgo sentinel lymph node biopsy

被引：0
|
作者：
Meves, Alexander [1 ]
Arias-Mejias, Suzette [1 ]
Bridges, Alina G. [1 ]
Lehman, Julia S. [2 ]
Pittelkow, Mark R. [2 ]
Cappel, Mark A. [2 ]
Perniciaro, Charles [3 ]
van Vliet, Martin H. [4 ]
Bellomo, Domenico [4 ]
Dwarkasing, Jvalini
Bellomo, Domenico [4 ]
机构：
[1] Mayo Clin, Rochester, MN USA
[2] Gulf Coast Dermatopathol Lab, Tampa, FL USA
[3] Univ Florida, Coll Med, Gainesville, FL 32611 USA
[4] SkylineDx BV, Rotterdam, Netherlands
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2020年 / 83卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
18408
引用
收藏
页码：AB99 / AB99
页数：1
相关论文
共 50 条
  • [31] Integrating 31-Gene Expression Profiling With Clinicopathologic Features to Optimize Cutaneous Melanoma Sentinel Lymph Node Metastasis Prediction
    Whitman, Eric D.
    Koshenkov, Vadim P.
    Gastman, Brian R.
    Lewis, Deri
    Hsueh, Eddy C.
    Pak, Ho
    Trezona, Thomas P.
    Davidson, Robert S.
    McPhee, Michael
    Guenther, J. Michael
    Toomey, Paul
    Smith, Franz O.
    Beitsch, Peter D.
    Lewis, James M.
    Ward, Andrew
    Young, Shawn E.
    Shah, Parth K.
    Quick, Ann P.
    Martin, Brian J.
    Zolochevska, Olga
    Covington, Kyle R.
    Monzon, Federico A.
    Goldberg, Matthew S.
    Cook, Robert W.
    Fleming, Martin D.
    Hyams, David M.
    Vetto, John T.
    JCO PRECISION ONCOLOGY, 2021, 5 : 1466 - 1479
  • [32] Can Histologic Parameters of Melanoma Metastases in Sentinel Lymph Nodes Reliably Select Patients Who Can Be Safely Spared Completion Lymph Node Dissection? Reply
    van der Ploeg, I. M. C.
    Kroon, B. B. R.
    Nieweg, O. E.
    Antonini, N.
    Olmos, R. A. Valdes
    ANNALS OF SURGERY, 2010, 251 (06) : 1189 - 1190
  • [33] Targeted High-Resolution Ultrasound Is Not an Effective Substitute for Sentinel Lymph Node Biopsy in Patients With Primary Cutaneous Melanoma
    Sanki, Amira
    Uren, Roger F.
    Moncrieff, Marc
    Tran, Kayla L.
    Scolyer, Richard A.
    Lin, Hui-Yi
    Thompson, John F.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (33) : 5614 - 5619
  • [34] Gene expression profile test (GEP) prediction of metastasis-free (MFS) and overall survival (OS) in a cohort of cutaneous melanoma (CM) patients undergoing sentinel lymph node biopsy (SLNB).
    Lawson, David H.
    Russell, Maria C.
    Wilkinson, Jeff
    Jackson, Gilchrist L.
    Greisinger, Anthony
    Amaria, Rodale N.
    Gonzalez, Rene
    Lyle, Stephen
    Johnson, Clare
    Oelschlager, Kristen M.
    Stone, John F.
    Maetzold, Derek
    Cook, Robert W.
    Ferris, Laura
    Delman, Keith A.
    Gerami, Pedram
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [35] Enhanced Risk Stratification for Sentinel Lymph Node Biopsy in Head and Neck Melanoma Using the Merlin Assay (CP-GEP) ( nov , 10.1245/s10434-024-16551-8 , 2024)
    Pazhava, Ani
    Yu, Wesley Y.
    Jing, Frank Z.
    Hill, Sheena
    Rohr, Bethany R.
    Honda, Kord S.
    Tjien-Fooh, Felicia
    Wever, Renske
    Dwarkasing, Jvalini
    Hieken, Tina J.
    Meves, Alexander
    ANNALS OF SURGICAL ONCOLOGY, 2025, : 3487 - 3487
  • [36] Correlation Between Gene Expression Profiling, Sentinel Lymph Node Biopsy Status, and Metastatic Risk in Primary Cutaneous Melanoma Cases - A Series of 206 Cases
    Sharma, Anurag
    Oaxaca, Gabriel
    Cook, Eleanor
    Duckworth, Lauren
    Frew, Derek
    McAfee, John
    Funchain, Pauline
    Billings, Steven
    Ronen, Shira
    Ko, Jennifer
    LABORATORY INVESTIGATION, 2022, 102 (SUPPL 1) : 358 - 358
  • [37] Correlation Between Gene Expression Profiling, Sentinel Lymph Node Biopsy Status, and Metastatic Risk in Primary Cutaneous Melanoma Cases - A Series of 206 Cases
    Sharma, Anurag
    Oaxaca, Gabriel
    Cook, Eleanor
    Duckworth, Lauren
    Frew, Derek
    McAfee, John
    Funchain, Pauline
    Billings, Steven
    Ronen, Shira
    Ko, Jennifer
    MODERN PATHOLOGY, 2022, 35 (SUPPL 2) : 358 - 358
  • [38] Performance of Gene Expression Profiling for Sentinel Lymph Node Sampling in Low Risk Thin Cutaneous Melanoma Patients
    Cools, K. S.
    Tsao, M.
    Deschner, B.
    Fowler, K.
    Hammond, J. B.
    Fleming, M.
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (SUPPL 1) : S104 - S104
  • [39] Sentinel lymph node biopsy has no benefit for patients with primary cutaneous melanoma metastatic to a lymph node: An assertion based on comprehensive, critical analysis Part I
    Medalie, NS
    Ackerman, AB
    AMERICAN JOURNAL OF DERMATOPATHOLOGY, 2003, 25 (05) : 399 - 417
  • [40] Sentinel lymph node biopsy has no benefit for patients with primary cutaneous melanoma metastatic to a lymph node: An assertion based on comprehensive, critical analysis - Part II
    Medalie, NS
    Ackerman, AB
    AMERICAN JOURNAL OF DERMATOPATHOLOGY, 2003, 25 (06) : 473 - 484
12345